Potential of mannan or dextrin nanogels as vaccine carrier/adjuvant systems

Detalhes bibliográficos
Autor(a) principal: Gonçalves, Catarina
Data de Publicação: 2016
Outros Autores: Ferreira, S., Correia, Alexandra L., Lopes, Célia, Fleming, Carolina E., Rocha, Eduardo, Vilanova, Manuel, Gama, F. M.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/1822/43871
Resumo: Polymeric nanogels have been sophisticatedly designed promising a new generation of vaccine delivery/adjuvant systems capable of boosting immune response, a strategic priority in vaccine design. Here, nanogels made of mannan or dextrin were evaluated for their potential as carriers/adjuvants in vaccine formulations. Since lymph nodes are preferential target organs for vaccine delivery systems, nanogels were biotin-labeled, injected in the footpad of rats, and their presence in draining lymph nodes was assessed by immunofluorescence. Nanogels were detected in the popliteal and inguinal lymph nodes by 24h upon subcutaneous administration, indicating entrapment in lymphatic organs. Moreover, the model antigen ovalbumin was physically encapsulated within nanogels and physicochemically characterized concerning size, zeta potential, ovalbumin loading, and entrapment efficiency. The immunogenicity of these formulations was assessed in mice intradermally immunized with ovalbuminmannan or ovalbumindextrin by determining ovalbumin-specific antibody serum titers. Intradermal vaccination using ovalbuminmannan elicited a humoral immune response in which ovalbumin-specific IgG1 levels were significantly higher than those obtained with ovalbumin alone, indicating a TH2-type response. In contrast, dextrin nanogel did not show adjuvant potential. Altogether, these results indicate that mannan nanogel is a material that should be explored as a future antigen delivery system.
id RCAP_81a310ea10c4abf837a9eeebbb8cd0a0
oai_identifier_str oai:repositorium.sdum.uminho.pt:1822/43871
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Potential of mannan or dextrin nanogels as vaccine carrier/adjuvant systemsMannanDextrinNanogelsLymph nodeOvalbuminVaccinationScience & TechnologyPolymeric nanogels have been sophisticatedly designed promising a new generation of vaccine delivery/adjuvant systems capable of boosting immune response, a strategic priority in vaccine design. Here, nanogels made of mannan or dextrin were evaluated for their potential as carriers/adjuvants in vaccine formulations. Since lymph nodes are preferential target organs for vaccine delivery systems, nanogels were biotin-labeled, injected in the footpad of rats, and their presence in draining lymph nodes was assessed by immunofluorescence. Nanogels were detected in the popliteal and inguinal lymph nodes by 24h upon subcutaneous administration, indicating entrapment in lymphatic organs. Moreover, the model antigen ovalbumin was physically encapsulated within nanogels and physicochemically characterized concerning size, zeta potential, ovalbumin loading, and entrapment efficiency. The immunogenicity of these formulations was assessed in mice intradermally immunized with ovalbuminmannan or ovalbumindextrin by determining ovalbumin-specific antibody serum titers. Intradermal vaccination using ovalbuminmannan elicited a humoral immune response in which ovalbumin-specific IgG1 levels were significantly higher than those obtained with ovalbumin alone, indicating a TH2-type response. In contrast, dextrin nanogel did not show adjuvant potential. Altogether, these results indicate that mannan nanogel is a material that should be explored as a future antigen delivery system.The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work is supported by the Fundação para a Ciência e a Tecnologia (FCT) Portugal, post-doc grant SFRH/BPD/70524/2010 and the International Iberian Nanotechnology Laboratory (INL), PhD grant. The authors thank the Portuguese Foundation for Science and Technology (FCT) under the scope of the strategic funding of UID/BIO/04469/2013 unit and COMPETE 2020 (POCI-01-0145-FEDER-006684). The authors also acknowledge the Project RECI/BBB-EBI/0179/2012 (FCOMP-01-0124-FEDER-027462).SAGE PublicationsUniversidade do MinhoGonçalves, CatarinaFerreira, S.Correia, Alexandra L.Lopes, CéliaFleming, Carolina E.Rocha, EduardoVilanova, ManuelGama, F. M.2016-092016-09-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/1822/43871engGonçalves, Catarina; Ferreira, S.; Correia, Alexandra L.; Lopes, Célia; Fleming, Carolina E.; Rocha, Eduardo; Vilanova, Manuel; Gama, F. M., Potential of mannan or dextrin nanogels as vaccine carrier/adjuvant systems. Journal of Bioactive and Compatible Polymers, 31(5), 453-466, 20160883-91151530-803010.1177/0883911516631354http://www.sagepub.com/journals/Journal201575info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-21T12:12:50Zoai:repositorium.sdum.uminho.pt:1822/43871Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T19:04:50.961510Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Potential of mannan or dextrin nanogels as vaccine carrier/adjuvant systems
title Potential of mannan or dextrin nanogels as vaccine carrier/adjuvant systems
spellingShingle Potential of mannan or dextrin nanogels as vaccine carrier/adjuvant systems
Gonçalves, Catarina
Mannan
Dextrin
Nanogels
Lymph node
Ovalbumin
Vaccination
Science & Technology
title_short Potential of mannan or dextrin nanogels as vaccine carrier/adjuvant systems
title_full Potential of mannan or dextrin nanogels as vaccine carrier/adjuvant systems
title_fullStr Potential of mannan or dextrin nanogels as vaccine carrier/adjuvant systems
title_full_unstemmed Potential of mannan or dextrin nanogels as vaccine carrier/adjuvant systems
title_sort Potential of mannan or dextrin nanogels as vaccine carrier/adjuvant systems
author Gonçalves, Catarina
author_facet Gonçalves, Catarina
Ferreira, S.
Correia, Alexandra L.
Lopes, Célia
Fleming, Carolina E.
Rocha, Eduardo
Vilanova, Manuel
Gama, F. M.
author_role author
author2 Ferreira, S.
Correia, Alexandra L.
Lopes, Célia
Fleming, Carolina E.
Rocha, Eduardo
Vilanova, Manuel
Gama, F. M.
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade do Minho
dc.contributor.author.fl_str_mv Gonçalves, Catarina
Ferreira, S.
Correia, Alexandra L.
Lopes, Célia
Fleming, Carolina E.
Rocha, Eduardo
Vilanova, Manuel
Gama, F. M.
dc.subject.por.fl_str_mv Mannan
Dextrin
Nanogels
Lymph node
Ovalbumin
Vaccination
Science & Technology
topic Mannan
Dextrin
Nanogels
Lymph node
Ovalbumin
Vaccination
Science & Technology
description Polymeric nanogels have been sophisticatedly designed promising a new generation of vaccine delivery/adjuvant systems capable of boosting immune response, a strategic priority in vaccine design. Here, nanogels made of mannan or dextrin were evaluated for their potential as carriers/adjuvants in vaccine formulations. Since lymph nodes are preferential target organs for vaccine delivery systems, nanogels were biotin-labeled, injected in the footpad of rats, and their presence in draining lymph nodes was assessed by immunofluorescence. Nanogels were detected in the popliteal and inguinal lymph nodes by 24h upon subcutaneous administration, indicating entrapment in lymphatic organs. Moreover, the model antigen ovalbumin was physically encapsulated within nanogels and physicochemically characterized concerning size, zeta potential, ovalbumin loading, and entrapment efficiency. The immunogenicity of these formulations was assessed in mice intradermally immunized with ovalbuminmannan or ovalbumindextrin by determining ovalbumin-specific antibody serum titers. Intradermal vaccination using ovalbuminmannan elicited a humoral immune response in which ovalbumin-specific IgG1 levels were significantly higher than those obtained with ovalbumin alone, indicating a TH2-type response. In contrast, dextrin nanogel did not show adjuvant potential. Altogether, these results indicate that mannan nanogel is a material that should be explored as a future antigen delivery system.
publishDate 2016
dc.date.none.fl_str_mv 2016-09
2016-09-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/1822/43871
url http://hdl.handle.net/1822/43871
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Gonçalves, Catarina; Ferreira, S.; Correia, Alexandra L.; Lopes, Célia; Fleming, Carolina E.; Rocha, Eduardo; Vilanova, Manuel; Gama, F. M., Potential of mannan or dextrin nanogels as vaccine carrier/adjuvant systems. Journal of Bioactive and Compatible Polymers, 31(5), 453-466, 2016
0883-9115
1530-8030
10.1177/0883911516631354
http://www.sagepub.com/journals/Journal201575
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv SAGE Publications
publisher.none.fl_str_mv SAGE Publications
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799132459281940480